威九(中国)国际

关于威九(中国)国际

致力于纳米抗体创新药物研发

关于威九(中国)国际

科研论文

截止现在，威九(中国)国际生物研发团队在具有重要影响力的期刊上发表研究论文多篇。

Efficient development of nanobody-based affinity chromatography for AAV8 purification.

发表于:Protein Expression and Purification

查看更多内容

Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology.

发表于:ACS Applied Materials & Interfaces

查看更多内容

A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.

发表于:J Allergy Clin Immunol.

查看更多内容

Nanobody-Based Microfluidic Immunosensor Chip Using Tetraphenylethylene-Derived Covalent Organic Frameworks as Aggregation-Induced Electrochemiluminescence Emitters for the Detection of Thymic Stromal Lymphopoietin.

发表于:Analytical Chemistry

查看更多内容

A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.

发表于:Journal of Nanobiotechnology.

查看更多内容

High performance production process development and scale-up of ananti-TSLP nanobody

发表于:Protein expression and purification, 218, 106441.

查看更多内容

总计 24 12 3 4